Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

CytomX Therapeutics- Inc. (CTMX)

23.94 -0.4 (-1.64%)

08-13 16:00

Open:

24.29

Pre. Close:

24.34

High:

24.38

Low:

23.62

Volume:

287,186

Market Cap:

1076M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

24.432 - 24.579

24.579 - 24.688

Low:

23.273 - 23.466

23.466 - 23.609

Close:

23.686 - 23.972

23.972 - 24.184

Technical analysis  (as of: 2018-08-13 4:28:50 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 29.80     One year: 31.77

Support:

Support1: 22.78    Support2: 18.95

Resistance:

Resistance1: 25.51    Resistance2: 27.20

Pivot:

25.35

Moving Averages:

MA(5): 24.71     MA(20): 25.16

MA(100): 25.65     MA(250): 23.84

MACD:

MACD(12,26): -0.05     Signal(12,26,9): 0.13

%K %D:

%K(14,3): 35.55     %D(3): 41.01

RSI:

RSI(14): 43.26

52-Week:

High: 35  Low: 13.51  Change(%): 71.0

Average Vol(K):

3-Month: 48526  10-Days 34127

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CTMX has closed above bottom band by 6.6%. Bollinger Bands are 27.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-08-08T16:16:10-04:00
CytomX misses by $0.03, beats on revenue

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

44.96

Shares Float (M)

44.49

% Held by Insiders

1.20

% Held by Institutions

71.40

Shares Short (K)

2157

Shares Short Prior Month (K)

Stock Financials

EPS

-1.010

EPS Est. Current Year

-1.490

EPS Est. Next Year

-1.410

EPS Est. Next Quarter

-0.410

Forward EPS

-2.081

Book Value (p.s.)

26.610

PEG Ratio

-9.28

Profit Margin

-44.46

Operating Margin

-71.84

Return on Assets (ttm)

-10.6

Return on Equity (ttm)

-82.6

Qtrly Rev. Growth

21.7

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.235

Qtrly Earnings Growth

Operating Cash Flow (M)

174.85

Levered Free Cash Flow (M)

10.64

Valuation

P/E

-23.70

P/E Growth Ratio

-0.02

P/BV

0.90

P/S

535429632.00

P/CF

6.16

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.